Dorthe Da Graça Thrige

Title: Dorthe Da Graça Thrige: Innovator in Immunomodulating Compounds

Introduction

Dorthe Da Graça Thrige is a notable inventor based in Valby, Denmark. He has made significant contributions to the field of immunology through his innovative research and development of pharmaceutical compounds. His work focuses on addressing various medical conditions that can benefit from immunomodulation.

Latest Patents

Dorthe Da Graça Thrige holds 1 patent related to immunomodulating compounds. This patent describes a novel heterocyclic compound and its pharmaceutical composition, which is designed for clinical treatment of conditions such as rheumatoid arthritis, multiple sclerosis, diabetes, asthma, transplantation, systemic lupus erythematosus, and psoriasis. The invention specifically relates to CD80 antagonists that inhibit the interactions between CD80 and CD28. Additionally, the patent outlines a method for screening compounds that can inhibit ligand-induced co-stimulatory receptor internalization pathways in immune competent human cells.

Career Highlights

Dorthe Da Graça Thrige is associated with Active Biotech AB, where he continues to advance his research in immunology. His work has the potential to lead to significant breakthroughs in the treatment of various autoimmune diseases and conditions that require immunomodulation.

Collaborations

Dorthe has collaborated with notable colleagues such as Per Axel Björk and Tomas Fex, contributing to a dynamic research environment that fosters innovation and discovery.

Conclusion

Dorthe Da Graça Thrige's contributions to the field of immunology through his patented innovations highlight his role as a key inventor in developing new therapeutic approaches. His work continues to pave the way for advancements in medical treatments that can improve patient outcomes.